Tag Archive for: Oligonucleotide discovery

acquisition

GSK closes US$50m acquisition with Elsie Biotechnologies Inc

GSK takes over Elsie Biotechnologies in US$50m deal to boost its oligonucleotide-based drug platform and pipeline.

Read more